Predictors of congestive heart failure after treatment with an endothelin receptor antagonist.
about
Diabetic Kidney Disease: Pathophysiology and Therapeutic TargetsDrugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers.Novel avenues for drug discovery in diabetic kidney disease.Rationale and protocol of the Study of Diabetic Nephropathy with Atrasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
P2860
Predictors of congestive heart failure after treatment with an endothelin receptor antagonist.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predictors of congestive heart ...... ndothelin receptor antagonist.
@en
Predictors of congestive heart ...... ndothelin receptor antagonist.
@nl
type
label
Predictors of congestive heart ...... ndothelin receptor antagonist.
@en
Predictors of congestive heart ...... ndothelin receptor antagonist.
@nl
prefLabel
Predictors of congestive heart ...... ndothelin receptor antagonist.
@en
Predictors of congestive heart ...... ndothelin receptor antagonist.
@nl
P2093
P2860
P356
P1476
Predictors of congestive heart ...... ndothelin receptor antagonist.
@en
P2093
Damien Green
Dick de Zeeuw
Giancarlo Viberti
Hiddo J Lambers Heerspink
Jamo Hoekman
Johannes F E Mann
P2860
P304
P356
10.2215/CJN.07040713
P577
2014-01-09T00:00:00Z